WO2005001019A1 - 胚様体形成用容器及び胚様体の形成方法 - Google Patents
胚様体形成用容器及び胚様体の形成方法 Download PDFInfo
- Publication number
- WO2005001019A1 WO2005001019A1 PCT/JP2004/008970 JP2004008970W WO2005001019A1 WO 2005001019 A1 WO2005001019 A1 WO 2005001019A1 JP 2004008970 W JP2004008970 W JP 2004008970W WO 2005001019 A1 WO2005001019 A1 WO 2005001019A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- container
- group
- embryoid body
- forming
- cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/06—Bioreactors or fermenters specially adapted for specific uses for in vitro fertilization
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/20—Material Coatings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/20—Small organic molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
Definitions
- the present invention relates to a container for forming an embryoid body used for forming an embryoid body and a method for forming an embryoid body.
- Embryonic stem cells have the ability to differentiate into various cells in vitro.
- Methods for differentiating ES cells in vitro include a method of forming a pseudo embryo called an embryoid body by suspension culture and a method of co-culturing with cells that support differentiation and proliferation, such as stromal cells.
- ES cells are cultured to a high density without the addition of leukemia inhibitory factor (LIF), and cultured in suspension so as not to adhere to a culture vessel such as a petri dish to form a cell mass. It is known to differentiate into different types of cells.
- LIF leukemia inhibitory factor
- EB embryoid body
- suspension culture is the most widely used method for differentiating ES cells in vitro.
- the embryoid body has a ball-like structure with double cell stratification, with the outer layer being the proximal endoderm and the inner layer being the embryonic ectoderm.
- the two germ layers are separated by a basement membrane.
- the structure closely resembles a cylindrical embryo, which is a 6-day embryo of a mouse, and so close to the normal developmental stage of the embryo.
- induction of mesoderm also occurs, and cardiomyocytes, blood cells, and even a primitive vascular network develop.
- the embryoid body When the embryoid body is attached to a culture dish and culture is continued, it differentiates into various types of cells. These include nerve cells, keratinocytes, chondrocytes, adipocytes and the like.
- the cells that differentiate through the formation of embryoid bodies are not limited to somatic cells, and it has recently been confirmed that differentiation into the germline occurs. Thus, the formation of embryoid bodies is convenient for showing the pluripotency of ES cells.
- the "no-nging-drop method" which is devised so that ES cells do not adhere to a culture vessel, is widely used.
- Hanging drop method in which ES cells are placed in a water drop hanging from the lid of a glass container for culturing.Drop method 1, or hanging method in which mineral oil is put in a culture vessel in advance and ES cells are layered on top of this and cultured.
- the hanging-drop method 2 using mineral oil microscopy cannot be performed until the embryoid body is transferred to another culture vessel after the formation of the embryoid body. R & D was very difficult.
- Patent Document 1 discloses that a method for producing 2-methacryloyloxetyl phosphorylcholine (hereinafter abbreviated as MP / C) and that a polymer thereof has excellent biocompatibility
- Patent Document 2 discloses that MP Patent Document 3 discloses that a copolymer of A / C and methacrylic acid ester is useful as a medical material that is less susceptible to adhesion and aggregation of platelets and adhesion of plasma proteins.
- Patent Documents 4 and 5 disclose that a medical material using a copolymer is coated with a polymer having a phosphorylcholine-like group on a resin surface to obtain excellent biocompatibility.
- a separating agent and a method for separating and recovering blood cells, cell lines, and primary culture cells are developed, respectively, by coating a polymer having a phosphorylcholine-like group onto polyethylene terephthalate. It is.
- Patent Document 1 JP-A-54-36025
- Patent Document 2 JP-A-3-39309
- Patent Document 3 JP-A-9-183819
- Patent Document 4 Japanese Patent Publication No. 6-502200
- Patent Document 5 Japanese Patent Publication No. 7-502053
- Patent Document 6 JP-A-2002-098676
- An object of the present invention is to provide an embryoid body-forming container used for easily forming an embryoid body from ES cells without using a complicated technique.
- Another object of the present invention is to provide a method for forming an embryoid body, which can easily culture an ES cell and form an embryoid body without using a complicated technique.
- a container for embryoid body formation for forming embryoid bodies by suspension culture of embryonic stem cells (ES cells), which forms a region for suspension culture of ES cells
- ES cells embryonic stem cells
- PC-like group a compound having a phosphorylcholine-like group represented by the formula (1)
- R 2 and R 3 are the same or different and represent a hydrogen atom, an alkyl group having 16 carbon atoms or a hydroxyalkyl group.
- n is an integer of 1 to 4.
- a coating layer formed using a compound having a PC-like group represented by the above formula (1) is provided on the surface of a container for forming a region for suspension culture of ES cells.
- a forming method is provided.
- an embryoid body formation container for forming an embryoid body by suspending and culturing ES cells, the surface of the container forming a region for suspending and culturing ES cells.
- the present invention also provides use of a container for forming an embryoid body, comprising a coating layer formed using a compound having a PC-like group represented by the above formula (1).
- the container for forming embryoid bodies of the present invention has a coating layer formed using a compound having a PC-like group on a desired surface, and thus is useful when forming embryoid bodies from ES cells.
- FIG. 1 is a copy of a phase contrast micrograph of an embryoid body formed in Example 2-1.
- FIG. 2 is a photocopy of phase-contrast microscopy of embryoid bodies cultured in Comparative Example 2-1 using an untreated plate.
- FIG. 3 is a copy of a phase contrast micrograph of an embryoid body formed by the hanging 'drop method performed in Comparative Example 2-2.
- the embryoid body-forming container of the present invention is a container used to form an embryoid body by suspending and culturing ES cells.
- the container is characterized in that a coating layer formed using a compound having a PC-like group represented by the above formula (1) is provided on a surface forming a region where ES cells are suspended and cultured.
- R 1 R 2 and R 3 are the same or different groups and represent a hydrogen atom, an alkyl group or a hydroxyalkyl group having 1 to 16 carbon atoms.
- Examples of the alkyl group having 16 carbon atoms include a methynole group, an ethyl group, a propyl group, a butyl group, a pentyl group, a hexyl group, a cyclohexyl group, and a phenyl group.
- Examples of the hydroxyalkyl group having 16 carbon atoms include a hydroxymethyl group, a 2-hydroxyethyl group, a 3-hydroxypropyl group, a 4-hydroxybutyl group, a 5-hydroxypentyl group, and a 6-hydroxyhexyl group. And the like.
- a reaction reagent containing a compound having a PC-like group is added to a desired surface of a container.
- a method of fixing a polymer having a PC-like group to a desired surface of a container by a coating method, and a method of fixing a polymer having a PC-like group to a desired surface of a container by a chemical bonding method is simple and easy.
- the polymer having a PC-like group may be a polymer having a PC-like group represented by the formula (1) .
- a PC-like group-containing monomer (M) represented by the formula (2) Preferred are at least one of a homopolymer and a copolymer of the monomer (M) and another monomer.
- R 2 , R 3 and n are the same as in formula (1), R 4 represents an alkyl group having 16 to 16 carbon atoms, and R 5 represents a hydrogen atom or a methyl group.
- the monomer (M) represented by the formula (2) for example, 2-((meth) atalyloyloxy) ethyl-2 ′ (trimethylammonio) ethyl phosphate, 3 ((meta) ) (Atariloyloxy) propyl 2 '(trimethylammonio) ethyl phosphate, 4 ((meth) atalyloyloxy) butyl-2- (trimethylammonio) ethyl phosphate, 5-(((meth) atalyloyloxy) ) Pentyl-2 (trimethylammonio) ethyl phosphate, 6 ((meth) atalyloyloxy) hexyl _2- (Trimethylammonio) ethyl phosphate, 2 _ ((meth) atalyloyloxy) ethynole (Triethylammonio) ethyl phosphate, 2 _ ((
- 2-((meth) atalyloyloxy) ethyl 2- (trimethylammonio) ethyl phosphate is preferred, and 2- (methacryloyloxy) ethyl 2- (trimethylammonio) ethyl phosphate (2 —Methacryloyloxetyl phosphorylcholine, MPC Abbreviation) is more preferable in terms of availability and the ability to prevent ES cells from adhering to the culture vessel, and exhibiting embryoid body-forming ability.
- Other monomers for obtaining the copolymer include a hydrophobic monomer, 2-hydroxyethyl (meth) acrylate, 2-hydroxybutyl (meth) acrylate, and 4-hydroxybutyl ( Hydroxyl-containing (meth) acrylates such as (meth) phthalate; acrylic acid, methacrylic acid, styrene sulfonate, (meth) atalyloyloxyphosphonic acid, 2-hydroxy_3- (meth) acryloxypropyltrimethylammonium ⁇ ⁇ ⁇ Ionic group-containing monomers such as muchloride, and nitrogen-containing monomers such as (meth) acrylamide, aminoethyl methacrylate, and dimethylaminoethyl (meth) atalylate
- hydrophobic monomer examples include methyl (meth) acrylate, ethyl (meth) acrylate, butyl (meth) acrylate, 2_ethylhexyl (meth) acrylate, and lauryl (meth) acrylate.
- the constitutional unit derived from a hydrophobic monomer is preferably 90 mol% or less, more preferably 20 90 mol%, in the constitutional unit of the copolymer.
- a copolymer having a structural unit derived from a hydrophobic monomer has improved elution resistance.
- the structural unit derived from a hydrophobic monomer exceeds 90 mol%, the formula (1) This is not preferable because the amount of the PC-like group represented by the formula (1) may decrease and the effect of the coating may not be sufficiently exhibited.
- the elution resistance is improved, and a surfactant or an organic solvent can be used in a medium or the like. Good.
- a copolymer using glycidinole (meta) acrylate can react with amino groups, propyloxyl groups, and the like on the surface of the container, and the copolymer can be chemically bonded to a desired surface.
- s can.
- the proportion of structural units derived from monomers other than the hydrophobic monomer is preferably 70 mol% or less.
- the molecular weight of the homopolymer of the PC-like group-containing monomer (M) represented by the formula (2) or the copolymer of the monomer (M) and another monomer is expressed by weight
- the average molecular weight is usually 5,000 to 500,000, and is preferably 100,000 to 2,000, 000, from the viewpoint that the adhesion of ES cells to the culture vessel can be effectively prevented, the embryoid body forming ability is expressed, and the elution resistance of the polymer is improved.
- the coating amount of the coating layer can be evaluated by a surface analysis method. Specifically, based on the spectrum measured by X-ray photoelectron spectroscopy, the peak area P of phosphorus and
- the P / C value for expressing embryoid body forming ability is preferably in the range of 0.002-0.3, and more preferably in the range of 0.01-0.2.
- the container for forming embryoid bodies of the present invention is not particularly limited, and for example, existing containers such as a cell culture dish, a cell culture multi-dish, a cell culture plate, a cell culture bag, and a cell culture flask. Cell culture vessels. In order to obtain an embryoid body of an appropriate size, a cell culture dish or a cell culture plate is more preferable.
- the material of the container for forming embryoid bodies is not particularly limited, and examples thereof include polystyrene, polypropylene, polyethylene, acrylic resin, glass, and metal.
- the surface of the container forming the coating layer is preferably a surface that has been subjected to surface processing such as corona treatment.
- a coating layer is formed at a desired location on the container surface using at least one of the homopolymer of the monomer ( ⁇ ⁇ ) and the copolymer of the monomer ( ⁇ ) and another monomer.
- the polymer is dissolved alone in water, ethanol, methanol, isopropanol, or the like, or dissolved in a mixed solvent of water and ethanol, ethanol and isopropanol, and then the container is immersed or placed in the container.
- the polymer solution etc. Can be applied.
- the copolymer has a chemically bondable functional group such as an epoxy group, an isocyanate group, a succinimide group, an amino group, a carboxy group, or a hydroxyl group, the amino group, the carboxyl group, or the hydroxyl group on the surface of the container may be used.
- a chemically bondable functional group such as an epoxy group, an isocyanate group, a succinimide group, an amino group, a carboxy group, or a hydroxyl group
- the amino group, the carboxyl group, or the hydroxyl group on the surface of the container may be used.
- the solution containing the copolymer is dissolved in a solvent that does not react with the chemically bondable functional groups, and chemically bonded to the surface of the container to form a coating layer.
- the container for embryoid body formation can also be obtained by the above method.
- the method for forming an embryoid body of the present invention uses a compound having a PC-like group represented by the above formula (1) on the surface of a container for forming a region for suspension culture of ES cells.
- Examples of the container prepared in the step (A) include the above-mentioned container for embryoid body formation of the present invention, and all the above-described containers can be applied to the container prepared in the step (A).
- the ES cells are cultured in suspension by, for example, culturing ES cells in an undifferentiated state cultured on a single feeder cell by a known method and conditions in the embryoid body formation container.
- the suspension culture can be carried out according to the following procedure.
- the culture solution in the embryoid body forming container may be shaken gently, even in a stationary state.
- IMDM medium Iscove's modified Dulbecco's medium
- the concentration of ES cells in the culture solution varies depending on the size and shape of the embryoid body formation container prepared in step (A), and is usually 1.0 ⁇ 10 2 ⁇ 1.0 ⁇ 10 6 cellsZmL. .
- the concentration of the ES cells when using 96 well plates can form a 1. 0 X 10 3 1. 0 X 10 5 It is cellsZmL force reproducibly embryoid bodies It is preferred.
- Sample A sample was dissolved in a mixed solvent containing 0.5% by weight of lithium bromide and mixed with formaldehyde / methanol (6/4 (volume ratio)) to prepare a 0.5% by weight polymer solution. .
- the amount of sample solution used is 20L.
- Elution solvent A mixed solvent of 0.5% by weight of lithium bromide in chloroform / methanol (6Z4 (vol%)) at a flow rate of 1. OmLZ.
- GMA isopropanol
- MPC 12.6 g
- BMA 8.6 g
- GMA 6.0 g
- MPC / BMA / GMA 30/40/30 (molar ratio) dissolved in 358 g of isopropanol, put into a four-necked flask, and blown with nitrogen for 30 minutes
- 2.18 g of a toluene solution of t_butyl peroxybivalate at 20% by weight at 60 ° C. was added and a polymerization reaction was performed for 5 hours, and the polymerization solution was not stirred in 3 L of getyl ether.
- copolymer (A) synthesized in Synthesis Example 1 0.5 g was dissolved in 100 mL of ethanol to prepare a copolymer solution. After 0.3 mL of the copolymer solution was placed in each well of a U-bottom polystyrene 96-well plate, the copolymer solution was removed from each well by suction. The container for embryoid body formation (A) was prepared by drying under reduced pressure at 50 ° C for 5 hours.
- a 96-well U-bottom polystyrene plate was subjected to corona treatment in air under the conditions of an irradiation energy of lj / cm 2 to generate carboxyl groups on the surface.
- 0.5 g of the copolymer (B) synthesized in Synthesis Example 2 was dissolved in 100 mL of isopropanol to prepare a copolymer solution. After 0.3 mL of the copolymer solution was placed in each well of a U-bottomed 96-well plate subjected to corona treatment, the copolymer solution was suctioned from each well and removed.
- a container for embryoid body formation (C) was prepared in the same manner as in Example 1-2, except that the copolymer (C) synthesized in Synthesis Example 3 was used instead of the copolymer (B).
- a 2 ⁇ 10 4 cellsZmL suspension of mouse ES cells prepared by the following preparation method was inoculated into each of the embryoid body formation containers (A) prepared in Example 11-1 in an amount of 0.2 mL per well. 37 ° C, 5% CO
- FIG. 1 shows a copy of a phase contrast micrograph.
- the evaluation of embryoid body formation in Table 2 is A when the embryoid body is large enough to differentiate and B when the embryoid body is formed but not large enough. C when no body was formed.
- SIM mouse fibroblasts (hereinafter abbreviated as STO cells) were used as one feeder cell.
- STO cells 25Units / mL penicillin, 25 g / mL streptomycin and 10 volume 0/0 inactivated treated ⁇ Shi calf serum (FCS) Dulbecco's modified Eagle's medium supplemented with (abbreviated hereinafter DMEM medium, manufactured by Gibco Co.) And cultured.
- FCS Shi calf serum
- DMEM medium Dulbecco's modified Eagle's medium supplemented with (abbreviated hereinafter DMEM medium, manufactured by Gibco Co.)
- the cultured STO cells were treated with lOgZmL of mitomycin C solution (Sigma) for 3 hours to obtain a cell suspension.
- the suspension of ST cells was seeded on each well in a 6-well multi-dish at 5 ⁇ 10 5 cells.
- Feeder cells were prepared by culturing at 37 ° C and 5% CO for 16 hours.
- ES cells As ES cells, 129V mouse ES cells were used. ES cell culture media were 15% KnockOut (registered trademark) serum replacement (KSR: Gibco), ImM sodium pyruvate (Gibco), 0. ImM nonessetial amino acids (Gibco), 0. ImM 2 — DMEM medium (hereinafter abbreviated as ES medium) containing menolecaptoethanol (Sigma), 25 units / mL penicillin, 25 g / mL streptomycin, and lOOOOunits / mL murine leukemia inhibitory factor (mLIF: Chemicon) . 2 ⁇ 10 5 cells / well ES cells were seeded on the feeder cell prepared in the above (1).
- KSR KnockOut (registered trademark) serum replacement
- KiSR Gibco
- ImM sodium pyruvate Gabco
- ImM nonessetial amino acids Gabco
- ImM 2 — DMEM medium hereinafter abbreviated as ES medium
- mice ES cells were cultured for 3 days under the conditions of 37 ° C and 5% CO.
- the mouse ES cells cultured in the above (2) were detached with 0.1% trypsin-EDTA in a usual manner, and then 15% FCS, 0. Suspension in IMDM medium containing ImM2-mercaptoethanol (Sigma), 25 units / mL penicillin and 25 g / mL streptomycin (Gibco, mLIF-free), 2 x 10 4 cells / mL suspension of mouse ES cells was prepared.
- Example 2-1 The experiment was performed in the same manner as in Example 2-1 except that an untreated 96-well polystyrene plate was used instead of the embryoid body formation container (A). Table 2 shows the results. Also, a phase contrast microscope The state of embryoid body formation was observed. A copy of this phase contrast micrograph is shown in FIG.
- the formed embryoid bodies were transferred to a U-bottom polystyrene 96-well plate. Then, observation was performed with a phase-contrast microscope in the same manner as in Example 2-1. Table 2 shows the results. Fig. 3 shows a copy of a phase contrast micrograph.
- Example 2 shows the results.
- Example 2-1 The embryoid body obtained in 1-2 was sucked out together with 0.1 mL of the medium and transferred to a gelatin-coated dish prepared by the following preparation method. The medium was exchanged every half day for half of the medium. After culturing for 7 days at 37 ° C and 5% CO, the cells were observed with a phase contrast microscope.
- the cells adhered to the bottom of the plate of Comparative Example 2-1 were transferred to a gelatin-coated dish, but could not be transferred.
- Example 3-1 An experiment was performed in the same manner as in Example 3-1 except that the embryoid bodies obtained in Comparative Example 2-2 (Comparative Example 3-2) and Comparative Example 2_3 (Comparative Example 3-3) were used. Table 3 shows the results.
- the P / C value was 0.038 to 0.074, and the embryoid body forming containers (A) to (C) It was found that it was covered with a coating layer of a polymer having a PC-like group. From Table 2, it was found that culturing mouse ES cells in the embryoid body formation containers (A)-(C) successfully formed embryoid bodies. From Table 3, it was found that the embryoid bodies formed from the embryonic body-forming vessels (A) and (C) and derived from mouse ES cells had a high ability to differentiate into myocardium.
- FIG. 1 it was found from FIG. 1 that the embryoid body having a size sufficient for differentiation was formed by using the embryoid body forming container according to the present invention. From FIG. 2, it was found that no embryoid body was formed in the case of the untreated polystyrene container.
- Figure 3 shows that the embryoid bodies formed by the hanging-drop method are not large enough.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Sustainable Development (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Clinical Laboratory Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK04746439.1T DK1657302T3 (da) | 2003-06-25 | 2004-06-25 | Fremgangsmåde til dannelse af embryoide legemer |
EP04746439A EP1657302B1 (en) | 2003-06-25 | 2004-06-25 | Method of forming embryoid bodies |
KR1020057024695A KR101068802B1 (ko) | 2003-06-25 | 2004-06-25 | 배양체 형성용 용기 및 배양체의 형성 방법 |
JP2005511038A JP4774989B2 (ja) | 2003-06-25 | 2004-06-25 | 胚様体形成用容器及び胚様体の形成方法 |
US10/562,015 US7648833B2 (en) | 2003-06-25 | 2004-06-25 | Container for germ layer formation and method of forming germ layer |
US12/480,156 US8278097B2 (en) | 2003-06-25 | 2009-06-08 | Method for forming embryoid bodies |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-181342 | 2003-06-25 | ||
JP2003181342 | 2003-06-25 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/562,015 A-371-Of-International US7648833B2 (en) | 2003-06-25 | 2004-06-25 | Container for germ layer formation and method of forming germ layer |
US12/480,156 Division US8278097B2 (en) | 2003-06-25 | 2009-06-08 | Method for forming embryoid bodies |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005001019A1 true WO2005001019A1 (ja) | 2005-01-06 |
Family
ID=33549525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/008970 WO2005001019A1 (ja) | 2003-06-25 | 2004-06-25 | 胚様体形成用容器及び胚様体の形成方法 |
Country Status (6)
Country | Link |
---|---|
US (2) | US7648833B2 (ja) |
EP (1) | EP1657302B1 (ja) |
JP (1) | JP4774989B2 (ja) |
KR (1) | KR101068802B1 (ja) |
DK (1) | DK1657302T3 (ja) |
WO (1) | WO2005001019A1 (ja) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007175008A (ja) * | 2005-12-28 | 2007-07-12 | Hiroshima Univ | 幹細胞の培養方法 |
JP2008523221A (ja) * | 2004-12-07 | 2008-07-03 | キー メディカル テクノロジーズ インコーポレイテッド | 眼用アプリケーション用ナノハイブリッドポリマー |
JP2008178367A (ja) * | 2007-01-26 | 2008-08-07 | Sumitomo Bakelite Co Ltd | 胚様体形成用培養容器と、その製造方法、及び胚様体形成方法。 |
JP2008220205A (ja) * | 2007-03-09 | 2008-09-25 | Sumitomo Bakelite Co Ltd | 神経幹細胞凝集塊形成用容器、その製造方法、及び神経幹細胞凝集塊の作成方法。 |
WO2009148170A1 (ja) * | 2008-06-06 | 2009-12-10 | 独立行政法人理化学研究所 | 幹細胞の培養方法 |
JP2011515084A (ja) * | 2008-03-18 | 2011-05-19 | セールス・エンジニアリング・アクチェンゲゼルシャフト | 幹細胞を生成するための血液、好ましくは末梢血を採取するためのキット |
US20120156696A1 (en) * | 2009-06-15 | 2012-06-21 | Shiseido Company, Ltd. | container for forming a cell aggregate and a method for forming a cell aggregate |
JP2016047902A (ja) * | 2014-08-28 | 2016-04-07 | 住友ベークライト株式会社 | 高分子化合物、コーティング材、コーティング材を被覆した成形体、並びにその製造方法 |
WO2016072369A1 (ja) * | 2014-11-04 | 2016-05-12 | 日油株式会社 | 胚様体形成用容器の製造方法 |
US10793830B2 (en) | 2009-11-05 | 2020-10-06 | Riken | Method for producing retinal tissue in vitro |
US10955410B2 (en) | 2016-05-24 | 2021-03-23 | Japanese Foundation For Cancer Research | Method of recovering extracellular vesicles and container for extracellular vesicles |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5095855B2 (ja) * | 2010-12-13 | 2012-12-12 | 株式会社 資生堂 | 細胞凝集塊の形成方法 |
JP2012210166A (ja) * | 2011-03-30 | 2012-11-01 | Sumitomo Bakelite Co Ltd | 胚様体形成用培養容器 |
KR101851825B1 (ko) | 2011-06-27 | 2018-04-24 | 니치유 가부시키가이샤 | 폴리머 및 그 제조 방법 |
WO2014165273A1 (en) | 2013-03-13 | 2014-10-09 | Innovative Surface Technologies, Inc. | Conical devices for three-dimensional aggregate (s) of eukaryotic cells |
WO2016002796A1 (ja) | 2014-06-30 | 2016-01-07 | 旭硝子株式会社 | タンパク質付着防止剤 |
JP7039473B2 (ja) * | 2016-07-29 | 2022-03-22 | ダイキン工業株式会社 | 分化細胞の製造方法、及びその製造方法のために使用する培養バッグ |
EP3621630A4 (en) | 2017-06-14 | 2021-03-10 | The Children's Medical Center | HEMATOPOIETIC STEM AND PRECURSOR CELLS FROM HEMOGENIC ENDOTHELIAL CELLS BY EPISOMAL PLASMID GENERAL TRANSFER |
CN112831005B (zh) | 2019-11-25 | 2022-08-12 | 青岛金典生化器材有限公司 | 细胞培养用的温敏性智能型基材及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002543828A (ja) * | 1999-05-14 | 2002-12-24 | イサム・リサーチ・デベロツプメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシテイ・オブ・エルサレム | 分化したヒト胚様体細胞およびこれらの作製方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5937383B2 (ja) | 1977-08-25 | 1984-09-10 | 株式会社ナカ技術研究所 | 建物用手摺の支柱 |
JP2890316B2 (ja) | 1989-07-07 | 1999-05-10 | 科学技術振興事業団 | 生体適合性医療デバイス用材料 |
GB9023498D0 (en) | 1990-10-29 | 1990-12-12 | Biocompatibles Ltd | Soft contact lens material |
US6284854B1 (en) | 1991-07-05 | 2001-09-04 | Biccompatibles Limited | Polymeric surface coatings |
CA2313676C (en) | 1991-07-05 | 2006-10-10 | Biocompatibles Limited | Polymeric surface coatings |
JP2634535B2 (ja) * | 1992-06-09 | 1997-07-30 | 住友ベークライト株式会社 | 足場依存性細胞の浮遊培養方法 |
JPH09183819A (ja) | 1995-12-28 | 1997-07-15 | Nippon Oil & Fats Co Ltd | リン脂質類似構造を有する共重合体及び医療材料 |
AU6366799A (en) * | 1998-12-24 | 2000-07-31 | Sumitomo Bakelite Company Limited | Container for immunologic assay |
-
2004
- 2004-06-25 KR KR1020057024695A patent/KR101068802B1/ko active IP Right Grant
- 2004-06-25 DK DK04746439.1T patent/DK1657302T3/da active
- 2004-06-25 WO PCT/JP2004/008970 patent/WO2005001019A1/ja active Search and Examination
- 2004-06-25 US US10/562,015 patent/US7648833B2/en active Active
- 2004-06-25 EP EP04746439A patent/EP1657302B1/en active Active
- 2004-06-25 JP JP2005511038A patent/JP4774989B2/ja active Active
-
2009
- 2009-06-08 US US12/480,156 patent/US8278097B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002543828A (ja) * | 1999-05-14 | 2002-12-24 | イサム・リサーチ・デベロツプメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシテイ・オブ・エルサレム | 分化したヒト胚様体細胞およびこれらの作製方法 |
Non-Patent Citations (2)
Title |
---|
ISHIHARA K. ET AL: "Inhibition of fibroblast cell adhesion on substrate by coating with 2-methacryloyloxyethyl phosphorylcholine polymers", J. BIOMATER. SCI. POLYMER EDN., vol. 10, no. 10, 1999, pages 1047 - 1061, XP002981312 * |
IWASAKI Y. ET AL: "The effect of the chemical structure of the phospholipid polymer on fibronectin adsorption and fibroblast adhesion on the gradient phospholipid surface", BIOMATERIALS, vol. 20, 1999, pages 2185 - 2191, XP002981313 * |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8420753B2 (en) | 2004-12-07 | 2013-04-16 | Key Medical Technologies, Inc. | Nanohybrid polymers for ophthalmic applications |
JP2008523221A (ja) * | 2004-12-07 | 2008-07-03 | キー メディカル テクノロジーズ インコーポレイテッド | 眼用アプリケーション用ナノハイブリッドポリマー |
US10421830B2 (en) | 2004-12-07 | 2019-09-24 | Key Medical Technologies, Inc. | Nanohybrid polymers for ophthalmic applications |
US9056934B2 (en) | 2004-12-07 | 2015-06-16 | Key Medical Technologies, Inc. | Nanohybrid polymers for ophthalmic applications |
JP2014031521A (ja) * | 2004-12-07 | 2014-02-20 | Key Medical Technologies Inc | 眼用アプリケーション用ナノハイブリッドポリマー |
JP2007175008A (ja) * | 2005-12-28 | 2007-07-12 | Hiroshima Univ | 幹細胞の培養方法 |
JP2008178367A (ja) * | 2007-01-26 | 2008-08-07 | Sumitomo Bakelite Co Ltd | 胚様体形成用培養容器と、その製造方法、及び胚様体形成方法。 |
JP2008220205A (ja) * | 2007-03-09 | 2008-09-25 | Sumitomo Bakelite Co Ltd | 神経幹細胞凝集塊形成用容器、その製造方法、及び神経幹細胞凝集塊の作成方法。 |
JP2011515084A (ja) * | 2008-03-18 | 2011-05-19 | セールス・エンジニアリング・アクチェンゲゼルシャフト | 幹細胞を生成するための血液、好ましくは末梢血を採取するためのキット |
US8500712B2 (en) | 2008-03-18 | 2013-08-06 | Thankstem Srl | Kit for collecting blood, preferably peripheral blood, for the production of stem cells |
JPWO2009148170A1 (ja) * | 2008-06-06 | 2011-11-04 | 独立行政法人理化学研究所 | 幹細胞の培養方法 |
WO2009148170A1 (ja) * | 2008-06-06 | 2009-12-10 | 独立行政法人理化学研究所 | 幹細胞の培養方法 |
US10227563B2 (en) | 2008-06-06 | 2019-03-12 | Riken | Method for culture of stem cell |
US10934523B2 (en) | 2008-06-06 | 2021-03-02 | Riken | Method for culture of stem cell |
US20120156696A1 (en) * | 2009-06-15 | 2012-06-21 | Shiseido Company, Ltd. | container for forming a cell aggregate and a method for forming a cell aggregate |
US9347031B2 (en) * | 2009-06-15 | 2016-05-24 | Shiseido Company, Ltd. | Container for forming a cell aggregate and a method for forming a cell aggregate |
US10793830B2 (en) | 2009-11-05 | 2020-10-06 | Riken | Method for producing retinal tissue in vitro |
JP2016047902A (ja) * | 2014-08-28 | 2016-04-07 | 住友ベークライト株式会社 | 高分子化合物、コーティング材、コーティング材を被覆した成形体、並びにその製造方法 |
EP3216856A4 (en) * | 2014-11-04 | 2018-07-18 | NOF Corporation | Method for producing container for forming embryoid body |
JPWO2016072369A1 (ja) * | 2014-11-04 | 2017-09-14 | 日油株式会社 | 胚様体形成用容器の製造方法 |
CN107075444A (zh) * | 2014-11-04 | 2017-08-18 | 日油株式会社 | 制备胚状体形成用容器的方法 |
KR20170082510A (ko) | 2014-11-04 | 2017-07-14 | 니치유 가부시키가이샤 | 배양체 형성용 용기의 제조 방법 |
WO2016072369A1 (ja) * | 2014-11-04 | 2016-05-12 | 日油株式会社 | 胚様体形成用容器の製造方法 |
US10955410B2 (en) | 2016-05-24 | 2021-03-23 | Japanese Foundation For Cancer Research | Method of recovering extracellular vesicles and container for extracellular vesicles |
Also Published As
Publication number | Publication date |
---|---|
US7648833B2 (en) | 2010-01-19 |
DK1657302T3 (da) | 2013-02-18 |
EP1657302A4 (en) | 2008-07-02 |
KR20060057543A (ko) | 2006-05-26 |
US20060252148A1 (en) | 2006-11-09 |
EP1657302B1 (en) | 2013-01-16 |
EP1657302A1 (en) | 2006-05-17 |
US8278097B2 (en) | 2012-10-02 |
JPWO2005001019A1 (ja) | 2006-10-19 |
US20090246871A1 (en) | 2009-10-01 |
JP4774989B2 (ja) | 2011-09-21 |
KR101068802B1 (ko) | 2011-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8278097B2 (en) | Method for forming embryoid bodies | |
JP6638706B2 (ja) | ブロック共重合体およびそれを用いた表面処理剤 | |
JP6451023B2 (ja) | 細胞培養基材 | |
WO2016159153A1 (ja) | 細胞培養基材、その製造方法、およびそれを用いた細胞培養方法 | |
JP4680361B2 (ja) | 分離・回収方法 | |
US9440004B2 (en) | Method for preparing biological tissue | |
Chou et al. | Surface zwitterionization on versatile hydrophobic interfaces via a combined copolymerization/self-assembling process | |
Jiang et al. | Toward label-free selective cell separation of different eukaryotic cell lines using thermoresponsive homopolymer layers | |
JP6565928B2 (ja) | 胚様体形成用容器の製造方法 | |
JP2018154752A (ja) | 共重合体およびその製造方法 | |
Hoess et al. | Co‐cultures of primary cells on self‐supporting nanoporous alumina membranes | |
JP7250248B2 (ja) | ブロック共重合体、それを含む表面処理剤及び膜、並びに、それを用いた細胞培養用器材及び細胞培養方法 | |
WO2017006694A1 (ja) | 細胞培養容器、装置、及び分離回収方法 | |
JP2018164412A (ja) | 細胞凝集塊形成用基材、細胞凝集塊の形成方法、物質のスクリーニング方法、細胞の機能探索方法、細胞培養基材用コーティング剤、及び細胞凝集塊形成促進剤 | |
Perestrelo et al. | Novel triblock co‐polymer nanofibre system as an alternative support for embryonic stem cells growth and pluripotency | |
WO2013051479A1 (ja) | 生体物質又は細胞の付着抑制剤 | |
US20220186179A1 (en) | Method for separating cells using a stimulus-responsive polymer | |
JP4405769B2 (ja) | 動物細胞固定化材及び動物細胞固定化方法 | |
Kuno et al. | Application of the water-insoluble, temperature-responsive block polymer poly (butyl methacrylate-block-N-isopropylacrylamide) for pluripotent stem cell culture and cell-selective detachment | |
JPH06153905A (ja) | 細胞培養基材および細胞培養方法 | |
Jiabei et al. | Protocols in stem cell culture | |
JP2021023249A (ja) | 細胞絆創膏 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005511038 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057024695 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004746439 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006252148 Country of ref document: US Ref document number: 10562015 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2004746439 Country of ref document: EP |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWP | Wipo information: published in national office |
Ref document number: 1020057024695 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 10562015 Country of ref document: US |